| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.4M | +31.0% |
| Cost of Revenue | $12.3M | +18.6% |
| Gross Profit | $19.1M | +40.5% |
| R&D Expense | $12.4M | +5.8% |
| SG&A Expense | $12.0M | +2.1% |
| Operating Income | -$19.7M | +12.0% |
| Income Tax | $12K | +50.0% |
| Net Income | -$18.9M | +14.4% |
| EPS (Basic) | -$0.70 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.1M | -13.1% |
| Accounts Receivable | $4.7M | +46.8% |
| Inventory | $6.9M | -13.2% |
| Current Assets | $33.4M | -7.8% |
| Total Assets | $39.2M | -8.1% |
| Current Liabilities | $10.4M | +39.3% |
| Total Liabilities | $13.8M | -35.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.9M | +34.8% |
| Capital Expenditures | $275K | -61.6% |
| Investing Cash Flow | -$275K | -103.1% |
| Financing Cash Flow | $6.2M | +1990.9% |
| Free Cash Flow | -$9.2M | +36.1% |
| +22.2% |
| EPS (Diluted) | -$0.70 | +22.2% |
| Stockholders' Equity |
| $25.4M |
| +19.9% |